Central Nervous System Neoplasms
Information
- Disease name
- Central Nervous System Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04525014 | Active, not recruiting | Phase 1 | RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors | January 26, 2023 | December 31, 2024 |
| NCT01180881 | Active, not recruiting | Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment | October 2009 | June 2024 | |
| NCT00329589 | Completed | Phase 1 | A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients | September 2005 | June 2010 |
| NCT00822432 | Completed | Coproporphyrine Isomers and Methotrexate Elimination | October 2007 | August 2011 | |
| NCT00185848 | Completed | Phase 1 | Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis | April 2005 | June 2013 |
| NCT00328458 | Completed | Phase 1 | EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients | February 2004 | July 2009 |
| NCT01931098 | Completed | Phase 2 | Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab | December 10, 2015 | September 12, 2019 |
| NCT02291822 | Completed | Retrospective Study of MRI in Pediatric Patients | November 2014 | December 2015 | |
| NCT03147989 | Completed | Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients | May 18, 2017 | March 16, 2018 | |
| NCT03188354 | Completed | N/A | Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma | November 1, 2017 | December 31, 2023 |
| NCT03257631 | Completed | Phase 2 | A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors | September 18, 2017 | September 14, 2023 |
| NCT03434262 | Completed | Phase 1 | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors | March 5, 2018 | May 24, 2024 |
| NCT03750188 | Completed | Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs | November 1, 2018 | October 16, 2019 | |
| NCT05850377 | Not yet recruiting | 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas | June 1, 2023 | May 31, 2026 | |
| NCT04541082 | Recruiting | Phase 1 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | October 26, 2020 | February 2025 |
| NCT04859543 | Recruiting | N/A | Pediatric Prospective Personalized Immune and Target Identification Trial | February 1, 2021 | December 31, 2024 |
| NCT05835687 | Recruiting | Phase 1 | Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors | April 27, 2023 | March 2028 |
| NCT05386108 | Recruiting | Phase 1/Phase 2 | Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer | August 31, 2022 | December 2025 |
| NCT01582152 | Terminated | Phase 1/Phase 2 | Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma | July 2012 | March 2016 |
| NCT04096716 | Terminated | Phase 1 | Mapping Draining Lymph Nodes in CNS Malignancies | December 3, 2019 | April 30, 2022 |
| NCT00629187 | Terminated | Phase 1 | Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy | April 2004 | April 2012 |
| NCT02095353 | Terminated | Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients | September 1, 2014 | March 7, 2017 | |
| NCT02692898 | Terminated | Biomarker Analysis of Central Nervous System Tumors | February 25, 2016 | November 15, 2019 | |
| NCT04671368 | Unknown status | N/A | Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology | February 2021 | February 2022 |
| NCT01579253 | Unknown status | Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients | April 2012 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016543